Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi and Merck Serono to collaborate in oncology

December 17, 2010
Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis

Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …

News

Pharma careers options – management in China

December 17, 2010
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …

Feature

New hepatitis C drug offers cure for more patients

December 17, 2010
Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …

News

Chime launches new healthcare comms venture

December 17, 2010
Medical Communications Chime Communications, David Rowley, Sandy Royden, healthcare comms agency, medical communications

Communications giant Chime is putting money into a new healthcare PR venture which will be run by the ex-global head …

News

Government consults on UK value-based pricing

December 17, 2010
Sales and Marketing ABPI, Drug pricing, pharma pricing, value-based pricing

The government has begun a consolutation process for its plans to change the way medicines are priced in the UK. …

News

Merck KGaA appoints new head of pharma

December 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …

Appointment

Government pushes on with major NHS reforms

December 16, 2010
GP consortia, Health and Wellbeing Boards, NHS, NHS Commissioning Board, NHS Operating Framework, NHS reforms, PCTs

The government has set out a roadmap for its wide-ranging NHS reform plans that promises no let up in the …

News

Reforms are a ‘risky business’ for the NHS

December 16, 2010
Civitas, GP commissioning, NHS, NHS reforms, PCTs

The government is taking a ‘big risk’ with NHS reforms that will hand GPs responsibility for commissioning services, according to …

News
ABPI

Novo rebuked after diabetes promotion breaches Code

December 16, 2010
Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly

Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …

News

Race on to find new Johnson & Johnson leader

December 16, 2010
Sales and Marketing Johnson & Johnson, recruitment

Johnson & Johnson is promoting two of its most senior executives as it prepares to replace William Weldon, its current …

News
Healthy Thinkers

Digital Pharma: Doing good in healthcare

December 15, 2010
Medical Communications Digital Pharma blog, Dose of Digital, Healthy Thinkers, corporate responsibility

A new online community has been launched to bring together suggestions for improving healthcare and the altruistic side of those …

News

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …

News

Patient deaths halt Lilly cancer trial

December 15, 2010
Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …

News

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010
Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …

Appointment

Publicis makes German digital healthcare acquisition

December 15, 2010
Medical Communications Digital District, Publicis Groupe, Publicis Healthware International, healthcare communications agency, medical communications, publicis

The healthcare arm of French communications giant Publicis Groupe has bought a German agency specialising in digital health comms to …

News

NHS cuts will push health service “to the limit”

December 14, 2010
Health Select Committee, King’s Fund, NHS, NHS Confederation, NHS reforms, king's fund, social services

MPs have issued a stark warning on the impact of Government spending plans on the England’s health services, saying they …

News

Bayer invests 35m euros in biologics production

December 14, 2010
Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production

Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …

News

GSK buys sports nutrition company for £162m

December 14, 2010
Sales and Marketing GSK, GlaxoSmithKline, Maximuscle, Maxinutrition, consumer healthcare, sports nutrition

GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …

News
Pfizer's New York headquarters

Pfizer withdraws hypertension drug Thelin

December 14, 2010
Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan

Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …

News

McNeil recalls Rolaids on particle contamination

December 14, 2010
Manufacturing and Production J&J, JJ, McNeil, Rolaids, particulate contamination, pharmaceutical manufacturing, product recalls

Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026